 Recent studies using a novel QAQC tool LaraTM System for the radiotracer injection process revealed that current means to detect infiltration do not completely identify all infiltrationsobstructions. Since infiltrations may not be visible in the standard field of view FOV and since the impact of a peripheral circulatory obstruction may not be visible even if an injection site is in the FOV, it is possible for reading and treating physicians to be unaware that a patients image and quantification has been impacted. Additionally, when current means do detect an infiltration, they under-represent the severity because they are not capturing that infiltrations often resolve during the uptake period. As a result, infiltrations or obstructions may cause SUV inaccuracy and could adversely impact staging and tumor assessments. 